Evaluating brain function and psychological effects of cell therapy in autoimmune hemolytic anemia
Official title: Brain Function and Psychological Assessment in Patients With Autoimmune Hemolytic Anemia Undergoing Cell Therapy
Run by Institute of Hematology & Blood Diseases Hospital, China · NCT06921980 · Data updated 2026-11-12
This study is testing how CAR T-cell therapy affects thinking and mental health in people with autoimmune hemolytic anemia to help improve their treatment and quality of life.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | Institute of Hematology & Blood Diseases Hospital, China Academic / other |
| Drugs / interventions | CAR T |
| Locations | 1 site (Tianjin, Tianjin Municipality) |
| Status | Recruiting |
| Started | February 25, 2025 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2028 |
| Registry record updated | November 4, 2026 |
| Trial ID | NCT06921980 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18-65 with a diagnosis of autoimmune hemolytic anemia who are set to receive cell therapy.
✕Probably not a fit
Patients with a history of psychiatric illness or severe brain disease may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study investigates the cognitive and psychological impacts of cell therapy, specifically CAR T-cell therapy, on patients diagnosed with autoimmune hemolytic anemia (AIHA). It aims to assess brain function and psychological well-being to identify potential impairments early, allowing for timely interventions. By understanding these effects, the study seeks to enhance treatment strategies and improve the overall quality of life for patients undergoing this innovative therapy.
Why it matters
Potential benefit: If successful, this study could lead to safer and more effective treatment strategies for patients with autoimmune hemolytic anemia.
How similar studies have gone: While cell therapy has shown promise in treating hematologic and autoimmune diseases, the specific focus on cognitive and psychological impacts in this context is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of AIHA * Subjects will receive cell therapy such as CAR T-cell therapy * Male or female, aged 18-65 years * Willing and able to comply with the requirements for this study and written informed consent Exclusion Criteria: * History of psychiatric illness * History of severe brain disease * Subjects that the investigator believes have other reasons that make them unsuitable for inclusion in this study
Where it's running
-
Regenerative Medicine Center
Tianjin, Tianjin Municipality, China Recruiting
Study contacts
- Study coordinator: Zhexiang Kuang, MSN
- Email: kuangzhexiang@ihcams.ac.cn
- Phone: 13920361752
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
CAR-T Therapy Safety, Response, and Immune-Escape: Observational Study in Adults
This observational study looks at adults who receive CAR-T cell therapy or bispecific antibodies to see which factors predict response and immune-related side effects.
-
Intraoperative Comfort After Cesarean with Neuraxial Anesthesia
This study tests how patients feel during cesarean delivery with spinal or epidural anesthesia to help create a tool that captures intraoperative comfort.
-
F182112 in relapsed/refractory autoimmune hemolytic anemia
A small early study tests F182112 as a single treatment for adults with AIHA that has not responded to other therapies, to see if it’s safe and what dose works best.
-
Human-created animated art vs AI-created art: does it change how you feel right away?
This online trial tests whether watching a human-made animated art film or an AI-made one, or doing nothing, quickly changes mood or sense of connection in U.S. adults.
-
Vicarious Post-Traumatic Growth Intervention for Emergency Nurses
This randomized trial tests whether a structured VPTG intervention helps emergency nurses reduce vicarious trauma and improve well-being.
-
Breathing before breastfeeding to help moms of NICU babies
This study tests whether pre-breastfeeding breathing exercises can reduce anxiety and improve well-being for mothers with babies in the NICU.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.